For research use only
| Cat No. | ABC-TC3946 |
| Product Type | Immune Cells |
| Cell Type | Mononuclear Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Multiple Myeloma |
| Storage | Liquid Nitrogen |
Utilize Human Multiple Myeloma Bone Marrow Mononuclear Cells (Newly Diagnosed/Untreated) to study tumor burden, drug sensitivity, and immunotyping.
Human Multiple Myeloma Bone Marrow Mononuclear Cells (Newly Diagnosed/Untreated) are isolated from the bone marrow of donors newly diagnosed with multiple myeloma and naïve to anticancer therapy. The cells are non-passaged and cryopreserved at primary isolation, and they display a mixed morphology with round malignant plasma cells and varying mononuclear subsets in suspension. Functionally, myeloma cells exhibit characteristic in vitro profiles including the secretion of monoclonal proteins, associated osteoclast activation activity, and immune surveillance evasion properties. The cells express CD38. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Multiple Myeloma Bone Marrow Mononuclear Cells (Newly Diagnosed/Untreated), MM BM-MNCs, Untreated Multiple Myeloma Bone Marrow MNCs, Newly Diagnosed Myeloma BM Cells |
| Species | Human |
| Cat.No | ABC-TC3946 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Mononuclear Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Bone Marrow |
| Disease | Multiple Myeloma |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Immune Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Multiple Myeloma Bone Marrow Mononuclear Cells (Newly Diagnosed/Untreated) serve as a relevant in vitro biological model for investigating the cellular and molecular mechanisms of multiple myeloma. This provides a better understanding of untreated myeloma cells’ physiological behavior in the native bone marrow niche, supporting discovery research and target identification for multiple myeloma.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).